Zusammenfassung
Hintergrund
Tuberkulose ist weiterhin die Infektionskrankheit, an welcher weltweit die meisten Menschen versterben.
Ziel des Beitrags
Die aktuelle Literatur zur Assoziation von Diabetes und Tuberkulose wird beschrieben, und Fragen des klinischen Managements bei Patienten mit beiden Diagnosen werden diskutiert.
Ansteckungsgefahr
Das Risiko, an einer Tuberkulose zu erkranken, ist bei Patienten mit Diabetes im Vergleich zur nicht an dieser Stoffwechselerkrankung leidenden Bevölkerung verdreifacht.
Therapie von an Tuberkulose erkrankten Diabetespatienten
Die Behandlungsergebnisse bezüglich der Tuberkulose sind bei Patienten mit vs. ohne Diabetes schlechter, und sowohl die Therapie der Tuberkulose als auch die des Diabetes werden durch Medikamenteninteraktionen erschwert.
Abstract
Background
Tuberculosis continues to be the infectious disease that kills the most people worldwide.
Objective
In this article we describe the current literature on the association between diabetes and tuberculosis, and discuss issues of clinical management of concurrent diagnosis of diabetes and tuberculosis.
Risk of infection
The risk of developing tuberculosis is three times higher in patients with diabetes compared to people without diabetes.
Treatment of diabetes patients with tuberculosis
Tuberculosis treatment outcomes are worse for patients with diabetes, and care of patients with both tuberculosis and diabetes is complicated by drug interactions.
Literatur
World Health Organization (2017) Global Tuberculosis Report 2017. World Health Organization, Genf
World Health Organization (2014) End TB Strategy. World Health Organization, Genf
Grillo VJ (1933) The type and distribution of pathology in pulmonary tuberculosis associated with diabetes mellitus. Yale J Biol Med 5(6):559–572
Dooley KE, Chaisson RE (2009) Tuberculosis and diabetes mellitus: convergence of two epidemics. Lancet Infect Dis 9(12):737–746
Jeon CY, Murray MB (2008) Diabetes mellitus increases the risk of active tuberculosis: a systematic review of 13 observational studies. Plos Med 5(7):e152
Al-Rifai RH, Pearson F, Critchley JA, Abu-Raddad LJ (2017) Association between diabetes mellitus and active tuberculosis: A systematic review and meta-analysis. PLoS ONE 12(11):e187967
Ponce-De-Leon A, Garcia-Garcia Md Mde L, Garcia-Sancho MC, Gomez-Perez FJ, Valdespino-Gomez JL, Olaiz-Fernandez G et al (2004) Tuberculosis and diabetes in southern Mexico. Diabetes Care 27(7):1584–1590
Lee MR, Huang YP, Kuo YT, Luo CH, Shih YJ, Shu CC et al (2017) Diabetes mellitus and latent tuberculosis infection: a systemic review and Metaanalysis. Clin Infect Dis 64(6):719–727
Baker MA, Harries AD, Jeon CY, Hart JE, Kapur A, Lonnroth K et al (2011) The impact of diabetes on tuberculosis treatment outcomes: a systematic review. BMC Med 9:81
Tegegne BS, Habtewold TD, Mengesha MM, Burgerhof JG (2017) Association between diabetes mellitus and multi-drug-resistant tuberculosis: a protocol for a systematic review and meta-analysis. Syst Rev 6(1):6
Odone A, Houben RM, White RG, Lonnroth K (2014) The effect of diabetes and undernutrition trends on reaching 2035 global tuberculosis targets. Lancet Diabetes Endocrinol 2(9):754–764
Pan SC, Ku CC, Kao D, Ezzati M, Fang CT, Lin HH (2015) Effect of diabetes on tuberculosis control in 13 countries with high tuberculosis: a modelling study. Lancet Diabetes Endocrinol 3(5):323–330
Martinez N, Kornfeld H (2014) Diabetes and immunity to tuberculosis. Eur J Immunol 44(3):617–626
Restrepo BI, Schlesinger LS (2013) Host-pathogen interactions in tuberculosis patients with type 2 diabetes mellitus. Tuberculosis (Edinb) 93(Suppl):S10–S4
Handel AE, Ramagopalan SV (2010) Tuberculosis and diabetes mellitus: is vitamin D the missing link? Lancet Infect Dis 10(9):596
Wang Q, Ma A, Han X, Zhang H, Zhao S, Liang H et al (2017) Is low serum 25-hydroxyvitamin D a possible link between pulmonary tuberculosis and type 2 diabetes? Asia Pac J Clin Nutr 26(2):241–246
Liao T‑L, Lin C‑F, Chen Y‑M, Liu H‑J, Chen D‑Y (2016) Risk factors and outcomes of Nontuberculous Mycobacterial disease among rheumatoid arthritis patients: a case-control study in a TB endemic area. Sci Rep 6:29443
Alim MA, Sikder S, Bridson TL, Rush CM, Govan BL, Ketheesan N (2017) Anti-mycobacterial function of macrophages is impaired in a diet induced model of type 2 diabetes. Tuberculosis (Edinb) 102:47–54
WHO (2011) Collaborative framework for care and control of tuberculosis and diabetes. WHO guidelines approved by the guidelines review committee. WHO, Genf
Maurice J (2011) WHO framework targets tuberculosis-diabetes link. Lancet 378(9798):1209–1210
Kapur A, Harries AD, Lonnroth K, Wilson P, Sulistyowati LS (2016) Diabetes and tuberculosis co-epidemic: the Bali Declaration. Lancet Diabetes Endocrinol 4(1):8–10
van Crevel R, Dockrell HM, Tandem Consortium (2014) TANDEM: understanding diabetes and tuberculosis. Lancet Diabetes Endocrinol 2(4):270–272
Jeon CY, Harries AD, Baker MA, Hart JE, Kapur A, Lonnroth K et al (2010) Bi-directional screening for tuberculosis and diabetes: a systematic review. Trop Med Int Health 15(11):1300–1314
Li L, Lin Y, Mi F, Tan S, Liang B, Guo C et al (2012) Screening of patients with tuberculosis for diabetes mellitus in China. Trop Med Int Health 17(10):1294–1301
Castellanos-Joya M, Delgado-Sanchez G, Ferreyra-Reyes L, Cruz-Hervert P, Ferreira-Guerrero E, Ortiz-Solis G et al (2014) Results of the implementation of a pilot model for the bidirectional screening and joint management of patients with pulmonary tuberculosis and diabetes mellitus in Mexico. PLoS ONE 9(9):e106961
Prakash BC, Ravish KS, Prabhakar B, Ranganath TS, Naik B, Satyanarayana S et al (2013) Tuberculosis-diabetes mellitus bidirectional screening at a tertiary care centre, South India. Public Health Action 3(Suppl 1):S18–S22
Lin Y, Li L, Mi F, Du J, Dong Y, Li Z et al (2012) Screening patients with diabetes mellitus for tuberculosis in China. Trop Med Int Health 17(10):1302–1308
Schaberg T, Bauer T, Brinkmann F, Diel R, Feiterna-Sperling C, Haas W et al (2017) S2k-Leitlinie: Tuberkulose im Erwachsenenalter. Pneumologie 71(06):325–397
Boillat-Blanco N, Ramaiya KL, Mganga M, Minja LT, Bovet P, Schindler C et al (2016) Transient hyperglycemia in patients with tuberculosis in Tanzania: implications for diabetes screening algorithms. J Infect Dis 213(7):1163–1172
Kumpatla S, Aravindalochanan V, Rajan R, Viswanathan V, Kapur A (2013) Evaluation of performance of A1c and FPG tests for screening newly diagnosed diabetes defined by an OGTT among tuberculosis patients – a study from India. Diabetes Res Clin Pract 102(1):60–64
World Health Organization (2018) Updated and consolidated guidelines for programmatic management. World Health Organization, Geneva
Chiang CY, Lee JJ, Chien ST, Enarson DA, Chang YC, Chen YT et al (2014) Glycemic control and radiographic manifestations of tuberculosis in diabetic patients. PLoS ONE 9(4):e93397
Riza AL, Pearson F, Ugarte-Gil C, Alisjahbana B, van de Vijver S, Panduru NM et al (2014) Clinical management of concurrent diabetes and tuberculosis and the implications for patient services. Lancet Diabetes Endocrinol 2(9):740–753
Wang JY, Lee MC, Shu CC, Lee CH, Lee LN, Chao KM et al (2015) Optimal duration of anti-TB treatment in patients with diabetes: nine or six months? Chest 147(2):520–528
Critchley JA, Restrepo BI, Ronacher K, Kapur A, Bremer AA, Schlesinger LS et al (2017) Defining a research agenda to address the converging epidemics of tuberculosis and diabetes: part 1: epidemiology and clinical management. Chest 152(1):165–173
Jørgensen ME, Faurholt-Jepsen D (2014) Is there an effect of glucose lowering treatment on incidence and prognosis of tuberculosis? A systematic review. Curr Diab Rep 14(7):505
Hossain MD, Ahmed JU, Rahim MA, Musa AKM, Latif ZA (2016) Bangladesh national guidelines on the management of tuberculosis and diabetes mellitus co-morbidity (summary). Indian J Endocrinol Metab 20(6):853–857
Tornio A, Niemi M, Neuvonen PJ, Backman JT (2012) Drug interactions with oral antidiabetic agents: pharmacokinetic mechanisms and clinical implications. Trends Pharmacol Sci 33(6):312–322
Boglou P, Steiropoulos P, Papanas N, Bouros D (2013) Hypoglycaemia due to interaction of glimepiride with isoniazid in a patient with type 2 diabetes mellitus. BMJ Case Rep. https://doi.org/10.1136/bcr-2012-008528
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Interessenkonflikt
B. Lange, A. Bockey, J.L.Z. Nyirenda und D. Wagner geben an, dass kein Interessenkonflikt besteht.
Dieser Beitrag beinhaltet keine von den Autoren durchgeführten Studien an Menschen oder Tieren.
Rights and permissions
About this article
Cite this article
Lange, B., Bockey, A., Nyirenda, J.L.Z. et al. Diabetes und Tuberkulose. Diabetologe 14, 160–165 (2018). https://doi.org/10.1007/s11428-018-0327-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11428-018-0327-x
Schlüsselwörter
- Glukosestoffwechselstörungen
- Infektion mit Mycobacterium tuberculosis
- Tuberkulostatika
- Antidiabetika
- Medikamenteninteraktionen